BNP Paribas Financial Markets Increases Stake in Globe Life Inc. $GL

BNP Paribas Financial Markets increased its holdings in Globe Life Inc. (NYSE:GL) by 14.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 170,331 shares of the company’s stock after acquiring an additional 21,115 shares during the period. BNP Paribas Financial Markets’ holdings in Globe Life were worth $23,822,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in GL. Allianz Asset Management GmbH lifted its stake in Globe Life by 55.2% in the 3rd quarter. Allianz Asset Management GmbH now owns 82,263 shares of the company’s stock valued at $11,761,000 after acquiring an additional 29,256 shares in the last quarter. Pzena Investment Management LLC raised its stake in shares of Globe Life by 5.6% during the 3rd quarter. Pzena Investment Management LLC now owns 998,506 shares of the company’s stock worth $142,756,000 after purchasing an additional 52,523 shares in the last quarter. SG Americas Securities LLC raised its stake in shares of Globe Life by 909.6% during the 4th quarter. SG Americas Securities LLC now owns 99,746 shares of the company’s stock worth $13,950,000 after purchasing an additional 89,866 shares in the last quarter. Tudor Investment Corp ET AL bought a new stake in shares of Globe Life during the 3rd quarter worth approximately $7,348,000. Finally, JPMorgan Chase & Co. raised its stake in shares of Globe Life by 11.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 247,947 shares of the company’s stock worth $35,449,000 after purchasing an additional 24,785 shares in the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on GL shares. Truist Financial upped their price objective on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Friday, April 24th. Wells Fargo & Company boosted their target price on Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a report on Friday, April 10th. Weiss Ratings raised Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 13th. Piper Sandler upped their price objective on Globe Life from $167.00 to $175.00 and gave the company an “overweight” rating in a report on Tuesday, May 26th. Finally, Texas Capital raised Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $174.11.

Insider Transactions at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 7,936 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $156.59, for a total value of $1,242,698.24. Following the completion of the sale, the chief financial officer owned 50,496 shares of the company’s stock, valued at approximately $7,907,168.64. This trade represents a 13.58% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Frank M. Svoboda sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $156.68, for a total value of $3,133,600.00. Following the completion of the sale, the chief executive officer directly owned 54,020 shares of the company’s stock, valued at $8,463,853.60. This trade represents a 27.02% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 105,929 shares of company stock worth $16,382,450. 2.11% of the stock is currently owned by insiders.

Globe Life Price Performance

Globe Life stock opened at $159.28 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $12.37 billion, a PE ratio of 11.02 and a beta of 0.49. Globe Life Inc. has a 12 month low of $116.73 and a 12 month high of $159.36. The stock has a 50-day moving average price of $150.46 and a two-hundred day moving average price of $143.44.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The company had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the business earned $3.07 earnings per share. Globe Life’s revenue was up 5.3% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Analysts expect that Globe Life Inc. will post 15.62 EPS for the current year.

Globe Life Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 annualized dividend and a yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is currently 9.13%.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.